Avalon Bioventures Management

Venture Capital Exempt reporting adviser

Legal name: Avalon Bioventures Management, LLC

LA Jolla, CA Website

AUM

$127.5M
Private fund assets

Private funds

1
Venture Capital 1

Private fund assets

$127.5M
Gross asset value

Employees

—

Last Form D raise

Jul 2021
Most recent fund filing

From SEC Form ADV filing (filed Mar 30, 2026). View on SEC

People(4)

Owners and executive officers named on the firm's SEC Form ADV.

J
Jay Lichter
Member and Manager
Source: SEC Form ADV
S
Sanford Madigan
Member and Manager
Source: SEC Form ADV
S
Sergio Duron
Member and Manager
Source: SEC Form ADV
T
Tighe Reardon
Member and Manager
Source: SEC Form ADV

Funds(1)

Private funds reported on Form ADV, with amounts raised from the funds' SEC Form D filings.

FundTypeGross assetsRaised (Form D)InvestorsLast Form DRecency
Avalon Bioventures I, LPVenture Capital$127.5M——Jul 2021Cold

Board seats(3)

Companies whose SEC Form D filings name one of this firm's people as a director, matched by name and office ZIP code.

Enlaza Therapeutics
PharmaceuticalsLA Jolla, CADirector: Sergio Duron
$134.3M raised
Since Mar 2021
SEC Form D
Valora Therapeutics
BiotechnologyLA Jolla, CADirector: Sanford Madigan
$13.0M raised
Since Jul 2024
SEC Form D
Ankasa Regenerative Therapeutics
BiotechnologyLA Jolla, CADirector: Sanford Madigan
$15.5M raised
Since Aug 2015
SEC Form D

Shares boards with

Firms whose people sit on the same company boards.

Avalon Ventures Management
Venture Capital
1 shared

Regulatory identifiers

CRD number
316674
SEC file number
802-122539

Sources